Formula Growth’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-81,000
Closed -$1.5M 136
2025
Q3
$1.5M Buy
+81,000
New +$1.67M 0.53% 70
2024
Q3
Sell
-85,620
Closed -$2.46M 118
2024
Q2
$2.46M Sell
85,620
-14,950
-15% -$458K 0.89% 43
2024
Q1
$2.93M Sell
100,570
-300
-0.3% -$8.39K 0.94% 45
2023
Q4
$3.28M Sell
100,870
-24,100
-19% -$699K 1.05% 34
2023
Q3
$4M Sell
124,970
-1,313
-1% -$50.6K 1.36% 16
2023
Q2
$5.54M Sell
126,283
-3,975
-3% -$183K 1.76% 10
2023
Q1
$5.77M Sell
130,258
-600
-0.5% -$26.5K 1.86% 8
2022
Q4
$5.2M Sell
130,858
-5,200
-4% -$217K 1.47% 15
2022
Q3
$6.28M Buy
136,058
+15,500
+13% +$760K 1.79% 8
2022
Q2
$5.2M Sell
120,558
-10,000
-8% -$457K 1.44% 21
2022
Q1
$7.05M Sell
130,558
-2,015
-2% -$103K 1.33% 20
2021
Q4
$7.94M Sell
132,573
-2,434
-2% -$152K 1.41% 21
2021
Q3
$8.84M Hold
135,007
1.27% 21
2021
Q2
$8.53M Buy
135,007
+23,000
+21% +$1.32M 1.18% 22
2021
Q1
$5.46M Buy
112,007
+67,007
+149% +$3.22M 0.79% 41
2020
Q4
$1.86M Hold
45,000
0.31% 85
2020
Q3
$2.07M Hold
45,000
0.39% 72
2020
Q2
$1.97M Hold
45,000
0.33% 79
2020
Q1
$1.78M Hold
45,000
0.34% 70
2019
Q4
$2.12M Hold
45,000
0.27% 83
2019
Q3
$1.59M Hold
45,000
0.24% 96
2019
Q2
$1.75M Hold
45,000
0.25% 93
2019
Q1
$1.99M Hold
45,000
0.28% 80
2018
Q4
$1.57M Buy
+45,000
New +$1.43M 0.26% 82

Other funds holding KIDS

Formula Growth's KIDS Position: Q4 2025 in Review

Formula Growth sold out of OrthoPediatrics (KIDS) in Q4 2025, closing a stake of 81,000 shares — an estimated $1.5M sold.

Formula Growth first reported a position in KIDS in Q4 2018 and held it in 24 quarters. The position peaked at $8.84M in Q3 2021. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.

  • Formula Growth reported no remaining OrthoPediatrics position as of Q4 2025 after selling out during the quarter.
  • Formula Growth sold 81,000 OrthoPediatrics shares in Q4 2025, an estimated $1.5M.
  • Formula Growth first reported a position in OrthoPediatrics in Q4 2018 and held it in 24 quarters.
  • Formula Growth's OrthoPediatrics position peaked at $8.84M in Q3 2021.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.

Based on Formula Growth's 13F filing for Q4 2025, filed 13 Feb 2026.